Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial.
暂无分享,去创建一个
B. Schmitz-Dräger | M. Grimm | G. Baretton | M. Pichler | C. Bolenz | G. Niegisch | F. Roghmann | K. Leucht | M. Schostak | W. Loidl | M. Schmitz | F. Zengerling | S. Foller | U. Schumacher | Christine Barbara Grün | Johannes Meran